These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 9510199

  • 1. Site-directed C3a receptor antibodies from phage display libraries.
    Hawlisch H, Frank R, Hennecke M, Baensch M, Sohns B, Arseniev L, Bautsch W, Kola A, Klos A, Köhl J.
    J Immunol; 1998 Mar 15; 160(6):2947-58. PubMed ID: 9510199
    [Abstract] [Full Text] [Related]

  • 2. The mouse anaphylatoxin C3a receptor: molecular cloning, genomic organization, and functional expression.
    Tornetta MA, Foley JJ, Sarau HM, Ames RS.
    J Immunol; 1997 Jun 01; 158(11):5277-82. PubMed ID: 9164946
    [Abstract] [Full Text] [Related]

  • 3. Molecular cloning of two isoforms of the guinea pig C3a anaphylatoxin receptor: alternative splicing in the large extracellular loop.
    Fukuoka Y, Ember JA, Hugli TE.
    J Immunol; 1998 Sep 15; 161(6):2977-84. PubMed ID: 9743361
    [Abstract] [Full Text] [Related]

  • 4. Cloning and characterization of rat C3a receptor: differential expression of rat C3a and C5a receptors by LPS stimulation.
    Fukuoka Y, Ember JA, Hugli TE.
    Biochem Biophys Res Commun; 1998 Jan 26; 242(3):663-8. PubMed ID: 9464274
    [Abstract] [Full Text] [Related]

  • 5. Modulation of C3a activity: internalization of the human C3a receptor and its inhibition by C5a.
    Settmacher B, Bock D, Saad H, Gärtner S, Rheinheimer C, Köhl J, Bautsch W, Klos A.
    J Immunol; 1999 Jun 15; 162(12):7409-16. PubMed ID: 10358194
    [Abstract] [Full Text] [Related]

  • 6. Expression cloning of the human C3a anaphylatoxin receptor (C3aR) from differentiated U-937 cells.
    Crass T, Raffetseder U, Martin U, Grove M, Klos A, Köhl J, Bautsch W.
    Eur J Immunol; 1996 Aug 15; 26(8):1944-50. PubMed ID: 8765043
    [Abstract] [Full Text] [Related]

  • 7. Ligand binding sites on guinea pig C3aR: point and deletion mutations in the large extracellular loop and vicinity.
    Fukuoka Y, Ember JA, Hugli TE.
    Biochem Biophys Res Commun; 1999 Sep 24; 263(2):357-60. PubMed ID: 10491297
    [Abstract] [Full Text] [Related]

  • 8. Antibody phage libraries for the next generation of tumor targeting radioimmunotherapeutics.
    DeNardo SJ, DeNardo GL, DeNardo DG, Xiong CY, Shi XB, Winthrop MD, Kroger LA, Carter P.
    Clin Cancer Res; 1999 Oct 24; 5(10 Suppl):3213s-3218s. PubMed ID: 10541366
    [Abstract] [Full Text] [Related]

  • 9. The receptor for complement anaphylatoxin C3a is expressed by myeloid cells and nonmyeloid cells in inflamed human central nervous system: analysis in multiple sclerosis and bacterial meningitis.
    Gasque P, Singhrao SK, Neal JW, Wang P, Sayah S, Fontaine M, Morgan BP.
    J Immunol; 1998 Apr 01; 160(7):3543-54. PubMed ID: 9531317
    [Abstract] [Full Text] [Related]

  • 10. Identification of ligand effector binding sites in transmembrane regions of the human G protein-coupled C3a receptor.
    Sun J, Ember JA, Chao TH, Fukuoka Y, Ye RD, Hugli TE.
    Protein Sci; 1999 Nov 01; 8(11):2304-11. PubMed ID: 10595533
    [Abstract] [Full Text] [Related]

  • 11. Role of the second extracellular loop of human C3a receptor in agonist binding and receptor function.
    Chao TH, Ember JA, Wang M, Bayon Y, Hugli TE, Ye RD.
    J Biol Chem; 1999 Apr 02; 274(14):9721-8. PubMed ID: 10092660
    [Abstract] [Full Text] [Related]

  • 12. Structure-function studies of the C3a-receptor: C-terminal serine and threonine residues which influence receptor internalization and signaling.
    Settmacher B, Rheinheimer C, Hamacher H, Ames RS, Wise A, Jenkinson L, Bock D, Schaefer M, Köhl J, Klos A.
    Eur J Immunol; 2003 Apr 02; 33(4):920-7. PubMed ID: 12672058
    [Abstract] [Full Text] [Related]

  • 13. Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers.
    Meli G, Visintin M, Cannistraci I, Cattaneo A.
    J Mol Biol; 2009 Apr 03; 387(3):584-606. PubMed ID: 19361429
    [Abstract] [Full Text] [Related]

  • 14. Selection and characterization of anti-MUC-1 scFvs intended for targeted therapy.
    Winthrop MD, DeNardo SJ, Albrecht H, Mirick GR, Kroger LA, Lamborn KR, Venclovas C, Colvin ME, Burke PA, DeNardo GL.
    Clin Cancer Res; 2003 Sep 01; 9(10 Pt 2):3845S-53S. PubMed ID: 14506182
    [Abstract] [Full Text] [Related]

  • 15. The C3a receptor antagonist SB 290157 has agonist activity.
    Mathieu MC, Sawyer N, Greig GM, Hamel M, Kargman S, Ducharme Y, Lau CK, Friesen RW, O'Neill GP, Gervais FG, Therien AG.
    Immunol Lett; 2005 Sep 15; 100(2):139-45. PubMed ID: 16154494
    [Abstract] [Full Text] [Related]

  • 16. [Cloning and expression of human single-chain Fv antibody against amyloid beta peptide involved in Alzheimer's disease].
    Cai J, Wang SZ, Peng Y, Zhong YW, Ji ZJ, Yuan JG, Qiang BQ.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Oct 15; 25(5):557-62. PubMed ID: 14650158
    [Abstract] [Full Text] [Related]

  • 17. Probing the human receptor for C5a anaphylatoxin with site-directed antibodies. Identification of a potential ligand binding site on the NH2-terminal domain.
    Oppermann M, Raedt U, Hebell T, Schmidt B, Zimmermann B, Götze O.
    J Immunol; 1993 Oct 01; 151(7):3785-94. PubMed ID: 8376805
    [Abstract] [Full Text] [Related]

  • 18. Anti-VEGFR-2 scFvs for cell isolation. Single-chain antibodies recognizing the human vascular endothelial growth factor receptor-2 (VEGFR-2/flk-1) on the surface of primary endothelial cells and preselected CD34+ cells from cord blood.
    Böldicke T, Tesar M, Griesel C, Rohde M, Gröne HJ, Waltenberger J, Kollet O, Lapidot T, Yayon A, Weich H.
    Stem Cells; 2001 Oct 01; 19(1):24-36. PubMed ID: 11209088
    [Abstract] [Full Text] [Related]

  • 19. Isolation of tumor cell-specific single-chain Fv from immunized mice using phage-antibody libraries and the re-construction of whole antibodies from these antibody fragments.
    Kettleborough CA, Ansell KH, Allen RW, Rosell-Vives E, Güssow DH, Bendig MM.
    Eur J Immunol; 1994 Apr 01; 24(4):952-8. PubMed ID: 8149964
    [Abstract] [Full Text] [Related]

  • 20. Human anaphylatoxin C4a is a potent agonist of the guinea pig but not the human C3a receptor.
    Lienenklaus S, Ames RS, Tornetta MA, Sarau HM, Foley JJ, Crass T, Sohns B, Raffetseder U, Grove M, Hölzer A, Klos A, Köhl J, Bautsch W.
    J Immunol; 1998 Sep 01; 161(5):2089-93. PubMed ID: 9725198
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.